UK markets close in 7 hours 9 minutes
  • FTSE 100

    7,121.02
    -32.41 (-0.45%)
     
  • FTSE 250

    22,569.25
    +34.11 (+0.15%)
     
  • AIM

    1,240.56
    -0.81 (-0.07%)
     
  • GBP/EUR

    1.1651
    -0.0038 (-0.33%)
     
  • GBP/USD

    1.3893
    -0.0031 (-0.22%)
     
  • BTC-GBP

    27,220.13
    -1,125.94 (-3.97%)
     
  • CMC Crypto 200

    941.05
    -28.83 (-2.97%)
     
  • S&P 500

    4,221.86
    -1.84 (-0.04%)
     
  • DOW

    33,823.45
    -210.22 (-0.62%)
     
  • CRUDE OIL

    70.70
    -0.34 (-0.48%)
     
  • GOLD FUTURES

    1,792.00
    +17.20 (+0.97%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • HANG SENG

    28,762.58
    +203.99 (+0.71%)
     
  • DAX

    15,683.39
    -44.28 (-0.28%)
     
  • CAC 40

    6,661.73
    -4.53 (-0.07%)
     

Global Nanobiotechnologies Markets Applications, & Companies Report 2021 Featuring 250+ Companies and their 185 Collaborations

·4-min read

Dublin, May 20, 2021 (GLOBE NEWSWIRE) -- The "Nanobiotechnologies - Applications, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Nanobiotechnology, an integration of physical sciences, molecular engineering, biology, chemistry and biotechnology holds considerable promise of advances in pharmaceuticals and healthcare.

The report starts with an introduction to various techniques and materials that are relevant to nanobiotechnology. It includes some of the physical forms of energy such as nanolasers. Some of the technologies are scaling down such as microfluidics to nanofluidic biochips and others are constructions from bottom up. Application in life sciences research, particularly at the cell level sets the stage for the role of nanobiotechnology in healthcare in subsequent chapters.

Some of the earliest applications are in molecular diagnostics. Nanoparticles, particularly quantum dots, are playing important roles. In-vitro diagnostics, does not have any of the safety concerns associated with the fate of nanoparticles introduced into the human body. Numerous nanodevices and nanosystems for sequencing single molecules of DNA are feasible. Various nanodiagnostics that have been reviewed will improve the sensitivity and extend the present limits of molecular diagnostics.

An increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries is anticipated. Nanotechnology will be applied at all stages of drug development - from formulations for optimal delivery to diagnostic applications in clinical trials. Many of the assays based on nanobiotechnology will enable high-throughput screening. Some of nanostructures such as fullerenes are themselves, drug candidates, as they allow precise grafting of active chemical groups in three-dimensional orientations.

The most important pharmaceutical applications are in drug delivery. Apart from offering a solution to solubility problems, nanobiotechnology provides and intracellular delivery possibilities. Skin penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices with autonomous operation guided by the needs.

Nanomedicine is now within the realm of reality starting with nanodiagnostics and drug delivery facilitated by nanobiotechnology. Miniature devices such as nanorobots could carry out integrated diagnosis and therapy by refined and minimally invasive procedures, nanosurgery, as an alternative to crude surgery. Applications of nanobiotechnology are described according to various therapeutic systems. Nanotechnology will markedly improve the implants and tissue engineering approaches as well.

Of the over 1,000 clinical trials of nanomedicines, approximately 100 are selected and tabulated in major therapeutic areas. Other applications such as for management of biological warfare injuries and poisoning are included. Contribution of nanobiotechnology to nutrition and public health such as the supply of purified water are also included.

There is some concern about the safety of nanoparticles introduced in the human body and released into the environment. Research is underway to address these issues. As yet there are no FDA directives to regulate nanobiotechnology but as products are ready to enter the market, these are expected to be in place.

Future nanobiotechnology markets are calculated on the basis of the background markets in the areas of application and the share of this market by new technologies and state of development at any given year in the future. This is based on a comprehensive and thorough review of the current status of nanobiotechnology, research work in progress and anticipated progress.

There is a definite indication of large growth of the market but it will be uneven and cannot be plotted as a steady growth curve. Marketing estimates are given according to areas of application, technologies and geographical distribution starting with 2020. The largest expansion is expected between the years 2024 and 2030.

Profiles of 252 companies, out of over 500 involved in this area, are included in the last chapter along with their 185 collaborations. The report is supplemented with 51 Tables, 32 figures and 800 references to the literature.

The report contains information on the following:

  • Nanobiotechnologies

  • Applications for research in life sciences

  • Nanomolecular diagnostics

  • Nanodevices and techniques

  • Nanopharmaceuticals

  • Nanooncology

  • Nanoneurology

  • Nanocardiology

  • Nanopulmonology

  • Nanoorthopedics

  • Nanoophthalmology

  • Miscellaneous clinical applications of nanobiotechnology

  • Nanobiotechnology and personalized medicine

  • Nanotoxicology

  • Regulatory and ethical issues

  • Research and future prospects

  • Markets

  • Companies

Key Topics Covered:

Part One: Applications & Markets

Executive Summary

1. Introduction

2. Nanotechnologies

3. Nanotechnologies for Basic Research Relevant to Medicine

4. Nanomolecular Diagnostics

5. Nanopharmaceuticals

6. Role of Nanotechnology in Biological Therapies

7. Nanodevices & Techniques for Clinical Applications

8. Nanooncology

9. Nanoneurology

10. Nanocardiology

11. Nanopulmonology

12. Nanoorthopedics

13. Nanoophthalmology

14. Nanomicrobiology

15. Miscellaneous Healthcare Applications of Nanobiotechnology

16. Nanobiotechnology and Personalized Medicine

17. Nanotoxicology

18. Ethical and Regulatory Aspects of Nanomedicine

19. Research and Future of Nanomedicine

20. Nanobiotechnology Markets

21. References

Part Two: Companies

22. Nanobiotech Companies

For more information about this report visit https://www.researchandmarkets.com/r/flixg0


CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting